An Australian stem cell and regenerative medicine company
About Us
About Us
What We Do
Board Of Directors
Management
Scientific Advisors
Corporate Governance
Company History
Clinical Development
Graft-versus-host-disease
Osteoarthritis
Acute respiratory distress syndrome
Diabetic Wounds
Renal transplantation
Pre-clinical Development
Asthma
Heart Attack
Coronary Artery Disease
Brain Cancer
Sepsis
Critical Limb Ischemia
Idiopathic pulmonary fibrosis
Science & Technology
Cymerus Technology
About MSCs
About iPSCs
Science Publications
Investors
Stock Information
ASX Announcements
Financial Reports
Presentations
Corporate Governance
Analyst Research
Investor FAQs
Right to Receive Documents
Newsroom
FAQ
Company FAQs
Investor FAQs
Contact Us
ASX Announcements
18 Feb 2019
Appendix 3B-Exercise of Options
11 Feb 2019
Appendix 3Y-Dr John Chiplin
11 Feb 2019
Cleansing Notice
11 Feb 2019
Appendix 3B-Exercise of Options
07 Feb 2019
Study of CYP-001 Published in Leading Peer Review Journal
04 Feb 2019
Cleansing Notice
04 Feb 2019
Appendix 3B-Exercise of Options
29 Jan 2019
December 2018 Quarterly Report
29 Jan 2019
Clinical trial results to be presented at major symposium
07 Jan 2019
CYP Receives Notice of Acceptance from Aust Patent Office
20 Dec 2018
End of Year Newsletter
18 Dec 2018
Cynata Completes Clinical Study Report in GvHD
13 Dec 2018
NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs
19 Nov 2018
Cynata Receives $1.3m R&D Tax Incentive Refund
15 Nov 2018
Replacement-Results of Annual General Meeting
15 Nov 2018
Results of Annual General Meeting
15 Nov 2018
Chairman's AGM Address
15 Nov 2018
Annual General Meeting Presentation
07 Nov 2018
CYP Receives Notice of Allowance from European Patent Office
01 Nov 2018
Cynata Clinical Trial Data Accepted for presentation at ASH
01 Nov 2018
Cynata Outlook and Investor Presentation
26 Oct 2018
Appendix 3Y-Dr Paul Wotton
23 Oct 2018
September 2018 Quarterly Report
17 Oct 2018
MSCs Demonstrate Anti-Cancer Effects in Pre-Clinical Studies
11 Oct 2018
Annual Report to Shareholders
11 Oct 2018
Notice of Annual General Meeting/Proxy Form
26 Sep 2018
Notification of 2018 Annual General Meeting Date
25 Sep 2018
Appendix 3Y-Stewart Washer
25 Sep 2018
Appendix 3Y-Dr Ross Macdonald
25 Sep 2018
Appendix 3Y-Dr Paul Wotton
25 Sep 2018
Cleansing Notice
25 Sep 2018
Appendix 3B-Exercise of Options
18 Sep 2018
Cynata MSCs Ameliorate CRS in Preclinical Study
12 Sep 2018
Results of Meeting
05 Sep 2018
Director Loan Funded Shares-Voluntary Escrow Arrangement
03 Sep 2018
Cynata Advances to Official Meeting with Japanese PDMA
31 Aug 2018
Cynata to Present at Rodman & Renshaw Investor Conference
29 Aug 2018
Cynata GvHD Trial Meets all Safety & Efficacy Endpoints
24 Aug 2018
Updated Appendix 4G
22 Aug 2018
Appendix 4G
22 Aug 2018
Appendix 4E & Financial Statements
10 Aug 2018
Notice of General Meeting/Proxy Form
30 Jul 2018
Cymerus MSCs improve cardiac recovery in preclinical study
16 Jul 2018
Cleansing Notice
16 Jul 2018
Appendix 3B-Exercise of Options
11 Jul 2018
Cleansing Notice
11 Jul 2018
Appendix 3B-Exercise of Options
11 Jul 2018
June 2018 Quarterly Report
06 Jul 2018
Cleansing Notice
06 Jul 2018
Appendix 3B-Exercise of Options
‹
1
2
3
4
5
6
7
8
9
10
11
›